During the proofing stage for the above article, [Table 3](#tab03){ref-type="table"} was modified incorrectly. It should have appeared as below: Table 3.Resistance (%) and distribution of MICs for the 106 ruminant STEC and 36 human STEC (O111/O157) isolates.Antimicrobial classAntimicrobial agentSource% Resistance[^a^](#tfn3_2){ref-type="table-fn"}No. of isolates at the indicated MIC (mg/l)0.0150.030.060.120.250.512481632641282565121024Aminoglycoside**Gentamicin**Ruminants0.083203Humans2.835**1***β*-Lactam**Ampicillin**Ruminants2.817851**3**Humans13.916141**5**Cephalosporin 3rd**Cefotaxime**Ruminants0.0106Humans0.036Cephalosporin 3rd**Ceftazidime**Ruminants0.0106Humans0.036Quinolone**Nalidixic acid**Ruminants0.0106Humans5.6331**2**(Fluoro)quinolone**Ciprofloxacin**Ruminants0.03571Humans0.036Sulfonamide**Sulfamethoxazole**[^**b**^](#tfn3_3){ref-type="table-fn"}Ruminants2.833646**3**Folate pathway inhibitor**Trimethoprim**Ruminants2.8722191**3**Folate pathway inhibitor / Sulfonamide**Trimethoprim/ Sulfamethoxazole**[^c^](#tfn3_4){ref-type="table-fn"}Humans16.7306Carbapenem**Meropenem**Ruminants0.01051**Imipenem**Humans0.0351**Ertapenem**Humans0.036Glycylcycline**Tigecycline**Ruminants0.0997Macrolide**Azithromycin**[^b^](#tfn3_3){ref-type="table-fn"}Ruminants0.0154501Miscellaneous**Chloramphenicol**Ruminants0.01024Polymyxin**Colistin**Ruminants0.01051Tetracycline**Tetracycline**Ruminants2.848532**3***β*-Lactam + *β*-lactamase inhibitor**Amoxicillin/clavulanic**Humans2.8[^**d**^](#tfn3_5){ref-type="table-fn"}30321Cephalosporin 2nd**Cefuroxime**Humans0.036Cephalosporin 2nd**Cefoxitin**Humans0.0324Cephalosporin 4th**Cefepime**Humans0.036Aminoglycoside**Tobramycin**Humans2.8[^**d**^](#tfn3_5){ref-type="table-fn"}351Organophosphonate**Fosfomycin**Humans0.036Nitrofuran**Nitrofurantoin**Humans0.0324[^1][^2][^3][^4][^5]

[^1]: White fields denote range of dilutions tested for each antimicrobial agent. MICs equal to or above the range are given as the concentration closest to the range and indicated in bold. MICs equal to or lower than the lowest concentration tested are given as the lowest tested concentration. Vertical lines indicate cut-off values: EUCAST epidemiological cut-offs (for ruminant isolates) are represented by thicker lines; CLSI clinical cut-offs (for human isolates) in thin lines, dashed for intermediate and continued for resistant.

[^2]: All resistant isolates belonged to serotype O157:H7.

[^3]: No cut-off value given by EUCAST; reference as indicated by double vertical lines were used.

[^4]: Trimethoprim/Sulfamethoxazole cut-off values are expressed as Trimethoprim concentration (range 1:19--16:304).

[^5]: Intermediate resistance.
